share_log

Aptose Biosciences Shares Are Trading Lower After the Company Announced the Pricing of an $8 Million Public Offering.

Benzinga ·  Nov 22 21:08
Aptose Biosciences Shares Are Trading Lower After the Company Announced the Pricing of an $8 Million Public Offering.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment